3 failures in new new product launches?
AR23
Lorcaserin
Eribulin
That's my guess.
And Zonegran? This company sure makes some great decisions, that is why I do not believe a word comming out of anyone in mgt mouth.Liars!!
It is amazing how Eisai has managed to fail every time. How much did Eisai pay for Zonegram? Then, got itself into a lawsuit? There is consistency: incompetent management.
There were more failures before the recent below: overpaid price for ONTK, Tagrentin; overpaid MGI, then Aloxi PONV, Lusedra, Banzile....
How about didn't know Zegerid was going generic and OTC unttill a week after it happened in April. what the hell goes on at HO? Definitely not average up[ there.
WHERE DID THE ENTRY GO REGARDING THE LAST THREE DIRECTOR HIRES BEING BLACK? AGAIN - LET ME REMIND YOU. ATLANTA, DALLAS, NOW CHICAGO - THEEZ BEEZ THE FACTS. MUST HAVE STRUCK A NERVE, BITHCHEZ.
Lusedra has failed as expected. MGI has really tricked Eisai for that.
I am wondering when Natio will fire LC for the overvalued MGI deal.
Never.....he's been here 15 plus years...why now...he will outlast us all!!!
Never.....he's been here 15 plus years...why now...he will outlast us all!!!